INTERNATIONAL BIOTECHNOLOGY TRUST PLC
Portfolio Update as at 30 November 2014
|
Net Assets |
£203m |
|
Net Assets per share |
476p |
|
Share price |
415p |
|
Total value of unquoted investments |
£18m |
|
Total number of portfolio companies |
82 |
Top Ten Holdings
|
Company Name |
% NAV |
|
Celgene |
9.8 |
|
Gilead |
6.4 |
|
Regeneron |
6.1 |
|
Chimerix |
5.1 |
|
Alexion |
5.0 |
|
Amgen |
4.8 |
|
Biogen-Idec |
4.2 |
|
Illumina |
3.6 |
|
Mylan |
3.1 |
|
Biomarin |
3.0 |
|
|
----------- |
|
Total |
51.1 |
|
Portfolio Profitability |
% NAV |
|
Profitable |
57 |
|
Turning Profitable 2015 |
7 |
|
Unprofitable |
36 |
|
|
----------- |
|
Total |
100 |
|
Geographical Allocation |
% NAV |
|
US & Canada |
90 |
|
Europe & UK |
10 |
|
|
----------- |
|
Total |
100 |
|
Quoted/Unquoted Allocation |
% NAV |
|
Quoted |
91 |
|
Unquoted |
9 |
|
|
----------- |
|
Total |
100 |
BNP Paribas Secretarial Services Limited
Company Secretary
22 DECEMBER 2014